Author:
Fokas Emmanouil,Williams Hannah,Diefenhardt Markus,Lin Sabrina,Qin Li-Xuan,Piso Pompiliu,Dapper Hendrik,Germer Christoph-Thomas,Grützmann Robert,Tim Friede J.,Joshua Smith J.,Saltz Leonard B.,Wu Abraham J.,Weiser Martin R.,Omer Dana,Ghadimi Michael,Hofheinz Ralf-Dieter,Garcia-Aguilar Julio,Rödel Claus
Funder
Deutsche Krebshilfe
National Cancer Institute
Universität zu Köln
Reference17 articles.
1. Outcome measures in multimodal rectal cancer trials;Fokas;Lancet Oncol,2020
2. Adoption of total neoadjuvant therapy for locally advanced rectal cancer;Cercek;JAMA Oncol,2018
3. Playing With dynamite? A cautious assessment of TNT;Shi;J Clin Oncol,2021
4. Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy;Smith;JAMA Oncol,2019
5. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial;Bahadoer;Lancet Oncol,2020